Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Naltrexone implants are a specialized formulation of naltrexone designed for subcutaneous insertion to provide extended-release treatment for opioid and alcohol dependence. These implants slowly dissolve in the body, continuously releasing naltrexone over a period of several months, typically 2-6 months depending on the specific formulation. The implants work by blocking opioid receptors in the brain, preventing the euphoric effects of opioids and reducing cravings for both opioids and alcohol. This extended-release formulation addresses a key challenge in addiction treatment: medication compliance. By providing continuous medication delivery, patients don't need to make daily decisions about taking their medication, which can significantly improve treatment outcomes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on naltrexone implant.